BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8900420)

  • 1. Incidence rates of leukemias, lymphomas and myelomas in Italy: geographic distribution and NHL histotypes.
    Masala G; Di Lollo S; Picoco C; Crosignani P; Demicheli V; Fontana A; Funtó I; Miligi L; Nanni O; Papucci A; Ramazzotti V; Rodella S; Stagnaro E; Tumino R; Viganó C; Vindigni C; Seniori Costantini A; Vineis P
    Int J Cancer; 1996 Oct; 68(2):156-9. PubMed ID: 8900420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and time trends for lymphomas, leukemias and myelomas: hypothesis generation. Working Group on the Epidemiology of Hematolymphopoietic Malignancies in Italy.
    Vineis P
    Leuk Res; 1996 Apr; 20(4):285-90. PubMed ID: 8642839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An Italian multicenter case-control study on malignant neoplasms of the hematolymphopoietic system. Hypothesis and preliminary results on work-related risks. WILL (Working Group on Hematolymphopoietic Malignancies in Italy)].
    Costantini AS; Miligi L; Vineis P
    Med Lav; 1998; 89(2):164-76. PubMed ID: 9673106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of non-Hodgkin's lymphoma and Hodgkin's disease in Sardinia, Italy: 1974-1993.
    Broccia G; Cocco P; Casula P;
    Haematologica; 2001 Jan; 86(1):58-63. PubMed ID: 11146572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Health databases to assess the incidence of lymphoid malignancies in Italian population].
    Borciani N; Vinceti M; Avanzini P; Ilariucci F; Mangone L; Martini M; Merlin M; Ferretti A; Frassineti M; Rodolfi R; Bergomi M
    Epidemiol Prev; 2000; 24(2):81-4. PubMed ID: 10863849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hodgkin's and non-Hodgkin's lymphomas.
    Hartge P; Devesa SS; Fraumeni JF
    Cancer Surv; 1994; 19-20():423-53. PubMed ID: 7534635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant lymphoma in western Ethiopia.
    Getachew A
    East Afr Med J; 2001 Aug; 78(8):402-4. PubMed ID: 11921560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
    Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
    Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lympho-hemopoietic malignancies in India.
    Bhutani M; Vora A; Kumar L; Kochupillai V
    Med Oncol; 2002; 19(3):141-50. PubMed ID: 12482124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Italian multicentre case-control study of hematolymphopoietic malignancies.
    Vineis P; Seniori Costantini A
    Med Lav; 1990; 81(6):506-12. PubMed ID: 2100766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence rates of lymphomas and environmental measurements of phenoxy herbicides: ecological analysis and case-control study.
    Fontana A; Picoco C; Masala G; Prastaro C; Vineis P
    Arch Environ Health; 1998; 53(6):384-7. PubMed ID: 9886156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pattern of haematological and lymphoreticular malignancy in Zimbabwe.
    Levy LM
    Trop Geogr Med; 1988 Apr; 40(2):109-14. PubMed ID: 3406999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent trends in the incidence of lymphomas in Kuwait.
    al-Bahar S; Pandita R; al-Bahar E; al-Muhana A; al-Yaseen N
    Neoplasma; 1996; 43(4):253-7. PubMed ID: 8931750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy and risk of lymphomas and myelomas.
    Altieri A; Gallus S; Franceschi S; Fernandez E; Talamini R; La Vecchia C
    Eur J Cancer Prev; 2004 Aug; 13(4):349-51. PubMed ID: 15554564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer incidence in the rural community of Tecumseh, Michigan: a pattern of increased lymphopoietic neoplasms.
    Waterhouse D; Carman WJ; Schottenfeld D; Gridley G; McLean S
    Cancer; 1996 Feb; 77(4):763-70. PubMed ID: 8616770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma.
    Ko YH; Kim CW; Park CS; Jang HK; Lee SS; Kim SH; Ree HJ; Lee JD; Kim SW; Huh JR
    Cancer; 1998 Aug; 83(4):806-12. PubMed ID: 9708949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed infection, family size and malignant lymphomas.
    Vineis P; Miligi L; Crosignani P; Fontana A; Masala G; Nanni O; Ramazzotti V; Rodella S; Stagnaro E; Tumino R; Viganò C; Vindigni C; Costantini AS
    J Epidemiol Community Health; 2000 Dec; 54(12):907-11. PubMed ID: 11076986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diet and risk of lymphoid neoplasms and soft tissue sarcomas.
    Tavani A; Pregnolato A; Negri E; Franceschi S; Serraino D; Carbone A; La Vecchia C
    Nutr Cancer; 1997; 27(3):256-60. PubMed ID: 9101555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haematopoietic cancer and medical history: a multicentre case control study.
    Vineis P; Crosignani P; Sacerdote C; Fontana A; Masala G; Miligi L; Nanni O; Ramazzotti V; Rodella S; Stagnaro E; Tumino R; Viganò C; Vindigni C; Costantini AS
    J Epidemiol Community Health; 2000 Jun; 54(6):431-6. PubMed ID: 10818118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.